Relmada Therapeutics Inc (RLMD)
3.68
-0.04
(-1.08%)
USD |
NASDAQ |
May 03, 16:00
3.66
-0.02
(-0.54%)
After-Hours: 20:00
Relmada Therapeutics Price: 3.68 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 3.80 | 3.93 | 3.63 | 3.68 | 92858.00 |
May 02, 2024 | 3.768 | 3.78 | 3.70 | 3.72 | 21845.00 |
May 01, 2024 | 3.62 | 3.83 | 3.62 | 3.69 | 64008.00 |
Apr 30, 2024 | 3.53 | 3.74 | 3.46 | 3.64 | 147724.0 |
Apr 29, 2024 | 3.85 | 3.969 | 3.35 | 3.53 | 241735.0 |
Apr 26, 2024 | 3.69 | 3.87 | 3.62 | 3.83 | 80013.00 |
Apr 25, 2024 | 3.79 | 3.81 | 3.66 | 3.70 | 85873.00 |
Apr 24, 2024 | 3.95 | 3.960 | 3.75 | 3.86 | 114592.0 |
Apr 23, 2024 | 3.91 | 4.10 | 3.82 | 3.91 | 143632.0 |
Apr 22, 2024 | 3.99 | 4.060 | 3.70 | 3.87 | 178128.0 |
Apr 19, 2024 | 4.30 | 4.314 | 3.950 | 4.00 | 152611.0 |
Apr 18, 2024 | 4.65 | 4.72 | 4.27 | 4.30 | 86256.00 |
Apr 17, 2024 | 4.62 | 4.72 | 4.52 | 4.68 | 85166.00 |
Apr 16, 2024 | 4.47 | 4.61 | 4.32 | 4.56 | 63203.00 |
Apr 15, 2024 | 4.67 | 4.730 | 4.413 | 4.45 | 125022.0 |
Apr 12, 2024 | 4.61 | 4.68 | 4.54 | 4.65 | 120024.0 |
Apr 11, 2024 | 4.60 | 4.81 | 4.495 | 4.66 | 117197.0 |
Apr 10, 2024 | 4.77 | 4.90 | 4.29 | 4.51 | 158446.0 |
Apr 09, 2024 | 4.92 | 5.09 | 4.745 | 4.80 | 88073.00 |
Apr 08, 2024 | 4.64 | 4.97 | 4.64 | 4.86 | 63172.00 |
Apr 05, 2024 | 4.72 | 4.840 | 4.53 | 4.59 | 101194.0 |
Apr 04, 2024 | 4.75 | 5.03 | 4.66 | 4.69 | 178512.0 |
Apr 03, 2024 | 4.96 | 5.09 | 4.68 | 4.71 | 144924.0 |
Apr 02, 2024 | 4.97 | 5.05 | 4.79 | 4.94 | 136600.0 |
Apr 01, 2024 | 4.65 | 5.00 | 4.60 | 4.88 | 126566.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.17
Minimum
Dec 08 2022
50.12
Maximum
Feb 26 2020
20.78
Average
22.25
Median
Dec 23 2021
Price Benchmarks
Cyclacel Pharmaceuticals Inc | 2.00 |
Lifecore Biomedical Inc | 6.39 |
Harrow Inc | 10.38 |
Corvus Pharmaceuticals Inc | 1.92 |
Aquestive Therapeutics Inc | 3.52 |
Price Related Metrics
PEG Ratio | -1.029 |
Price to Book Value | 1.301 |
Earnings Yield | -88.86% |
Market Cap | 111.04M |
PEGY Ratio | -1.029 |